UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory. Other researchers had previously used different cell types in rodent cell transplantation experiments and failed to stop seizures.
Cell therapy has become an active focus of epilepsy research, in part because current medications, even when effective, only control symptoms and not underlying causes of the disease, according to Scott C. Baraban, PhD, who holds the William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF and led the new study. In many types of epilepsy, he said, current drugs have no therapeutic value at all.
“Our results are an encouraging step toward using inhibitory neurons for cell transplantation in adults with severe forms of epilepsy,” Baraban said. “This procedure offers the possibility of controlling seizures and rescuing cognitive deficits in these patients.”
The findings, which are the first ever to report stopping seizures in mouse models of adult human epilepsy, will be published online May 5 in the journal Nature Neuroscience.
During epileptic seizures, extreme muscle contractions and, often, a loss of consciousness can cause seizure sufferers to lose control, fall and sometimes be seriously injured. The unseen malfunction behind these effects is the abnormal firing of many excitatory nerve cells in the brain at the same time.
In the UCSF study, the transplanted inhibitory cells quenched this synchronous, nerve-signaling firestorm, eliminating seizures in half of the treated mice and dramatically reducing the number of spontaneous seizures in the rest. Robert Hunt, PhD, a postdoctoral fellow in the Baraban lab, guided many of the key experiments.
In another encouraging step, UCSF researchers reported May 2 that they found a way to reliably generate human MGE-like cells in the laboratory, and that, when transplanted into healthy mice,the cells similarly spun off functional inhibitory nerve cells. That research can be found online in the journal Cell Stem Cell.
In many forms of epilepsy, loss or malfunction of inhibitory nerve cells within the hippocampus plays a critical role. MGE cells are progenitor cells that form early within the embryo and are capable of generating mature inhibitory nerve cells called interneurons. In the Baraban-led UCSF study, the transplanted MGE cells from mouse embryos migrated and generated interneurons, in effect replacing the cells that fail in epilepsy. The new cells integrated into existing neural circuits in the mice, the researchers found.
“These cells migrate widely and integrate into the adult brain as new inhibitory neurons,” Baraban said. “This is the first report in a mouse model of adult epilepsy in which mice that already were having seizures stopped having seizures after treatment.”
The mouse model of disease that Baraban’s lab team worked with is meant to resemble a severe and typically drug-resistant form of human epilepsy called mesial temporal lobe epilepsy, in which seizures are thought to arise in the hippocampus. In contrast to transplants into the hippocampus, transplants into the amygdala, a brain region involved in memory and emotion, failed to halt seizure activity in this same mouse model, the researcher found.
The Latest Bing News on:
Epilepsy
- NC med student creates device for people living with epilepsyon April 26, 2024 at 2:54 pm
Sanders invented the NuroVice, a device aimed at improving the qualify of life of people with epilepsy. >> Channel 9′s Gina Esposito learned it’s now being piloted at Atrium Health. She explains how ...
- Gene linked to epilepsy and autism decoded in new studyon April 26, 2024 at 11:04 am
A genetic change or variant in a gene called SCN2A is a known cause of infantile seizures, autism spectrum disorder, and intellectual disability, as well as a wide range of other moderate-to-profound ...
- What's Behind a Woman's 43-Year History of Drug-Resistant Epilepsy?on April 26, 2024 at 8:54 am
The patient's medical history indicated that she had been diagnosed with drug-resistant epilepsy more than 40 years before, at the age of 12, reported Seyed Mirsattari, MD, PhD, of Western University ...
- Are Epilepsy Patients At Greater Risk of Depression? Expert Explainson April 25, 2024 at 2:14 pm
Depression appears to be a significant mental health issue for people with Epilepsy due to shared neurobiology and psychosocial factors nbsp; ...
- Seizure dogs may reduce seizures for people with severe refractory epilepsy: Studyon April 25, 2024 at 10:00 am
Netherlands: A recent study published in the online issue of Neurology, the medical journal of the American Academy of Neurology, has shed light on the effectiveness of seizure dogs for people with ...
- Epilepsyon April 25, 2024 at 12:50 am
Kerry Smith was diagnosed with epilepsy more than a decade ago but struggled to find help locally. Families are heartbroken to be left out of a scheme proposing support for other patients. Patient ...
- Johns Hopkins epilepsy device spinout names new CEOon April 24, 2024 at 11:34 am
The company is raising $1.5 million as it seeks FDA approval for an application that turns an Apple Watch into a seizure detector.
- Mum’s epilepsy misdiagnosed and dismissed as ‘mental health problem’on April 24, 2024 at 6:31 am
After her panic attacks were dismissed as ‘ mental health problems,’ a young mum discovered that she wasn’t suffering from a mental illness: she had epilepsy.
- Mum diagnosed with epilepsy after symptoms dismissed as panic attackson April 24, 2024 at 3:11 am
A mum has been diagnosed with epilepsy after her symptoms were initially dismissed as panic attacks. Madeleine Dippnall, 29, was told by doctors that she was suffering from panic attacks caused by ...
- What is the Epilepsy Foundation’s Multicultural Outreach Program?on April 23, 2024 at 7:25 am
According to the Centers for Disease Control and Prevention, racial and ethnic minorities represent more than 40% of the 3.4 million people living with epilepsy in the United States. During National ...
The Latest Google Headlines on:
Epilepsy
[google_news title=”” keyword=”Epilepsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cell therapy
- Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City siteon April 26, 2024 at 7:59 am
One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in the Bay Area concentrated on the tumor microenvironment. | Bristol Myers ...
- CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumorson April 25, 2024 at 11:30 pm
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell ...
- BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohorton April 25, 2024 at 6:55 am
(NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced completion of enrollment and collection of the primary ...
- John Cleese is spending thousands on stem cell therapy – is it really the secret to anti-ageing?on April 24, 2024 at 9:59 pm
The procedure in question is stem cell therapy, a treatment that the Monty Python star undergoes every 12 to 18 months. “These cells travel around the body and when they discover a place that needs ...
- 2025 Cell & Gene Therapy Reimbursement Outlookon April 24, 2024 at 1:00 pm
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
- New device improves stem cell generation and chance for accessible Alzheimer's cell therapyon April 24, 2024 at 12:11 pm
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance that they say helps close the gap for accessible personalized cell-based ...
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 10:50 am
Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics ...
- LSU researchers develop syringe device for enhanced stem cell therapyon April 24, 2024 at 6:00 am
LSU researchers led by veterinary medicine professor Mandi Lopez have introduced a groundbreaking syringe device that could revolutionize tendon injury treatment.
- CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trialon April 24, 2024 at 5:32 am
Researchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have published results of a Phase ...
- Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidateson April 24, 2024 at 4:25 am
Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is ...
The Latest Google Headlines on:
Cell therapy
[google_news title=”” keyword=”Cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]